SCHEMBL22942153

SCHEMBL22942153

CCc1cc(Nc2ncc(Cl)c(Nc3ccc(C)c(C)c3P(C)(C)=O)n2)c(OC)cc1N1CCN2CCCC[C@@H]2C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 14/20 0.59
▸ INSR P06213 7/20 0.55
▸ IGF1R P08069 7/20 0.55
▸ ALK Q9UM73 7/20 0.55
▸ CHEK1 O14757 1/20 0.49
▸ AURKA O14965 1/20 0.49
▸ NUAK1 O60285 1/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ STK10 O94804 1/20 0.49
▸ PRKD3 O94806 1/20 0.49
▸ SLC34A2 O95436 1/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ CD74 P04233 1/20 0.49
▸ ERBB2 P04626 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ FES P07332 1/20 0.49
▸ CSF1R P07333 1/20 0.49
▸ YES1 P07947 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22942225 0.92 EGFR (0.67) EGFRINSRIGF1RALK
SCHEMBL29559850 0.91 EGFR (0.66) EGFRINSRIGF1RALK
SCHEMBL22942870 0.91 EGFR (0.66) EGFRINSRIGF1RALK
SCHEMBL22942158 0.89 LRRK2 (0.50) EGFRINSRIGF1RALKLRRK2
SCHEMBL22942144 0.89 INSR (0.69) EGFRINSRIGF1RALKCHEK1
SCHEMBL22950927 0.89 EGFR (0.64) EGFRINSRIGF1RALKCHEK1
SCHEMBL22950925 0.89 EGFR (0.64) EGFRINSRIGF1RALKCHEK1
SCHEMBL24940078 0.88 EGFR (0.60) EGFRINSRIGF1RALK
SCHEMBL30105850 0.88 EGFR (0.60) EGFRINSRIGF1RALK
SCHEMBL22942164 0.88 EGFR (0.60) EGFRINSRIGF1RALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021018003-A1 EGFR INHIBITOR, COMPOSITION, AND PREPARATION METHOD THEREFOR 贝达药业股份有限公司 2021-02-04 — — WO disclosed
Send feedback